Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SI-614 in Dry Eye
NCT02205840Phase 3Completed
- Sponsor
- Seikagaku Corporation
- Start
- Jul 2014
- Primary completion
- Nov 2014
- Modality
- Polymer-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 3 trial of cinhyaluronate sodium in dry eye syndrome (DED), sponsored by Seikagaku Corporation. Started Jul 2014; status: completed.
02
Drugs
cinhyaluronate sodium
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT02205840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02205840.